ROVALPITUZUMAB TESIRINE

UNII:	P256HB60FF
Formula:
Preferred Substance Name:	ROVALPITUZUMAB TESIRINE

1613313-09-9
IMMUNOGLOBULIN G1, ANTI-(PROTEIN DLL3 (DELTA-LIKE LIGAND 3)) (HUMAN-MUS MUSCULUS MONOCLONAL SC0001 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL SC0001 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(31-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1,29-DIOXO-4,7,10,13,16,19,22,25-OCTAOXA-28-AZAHENTRIACONT-1-YL)-L-VALYL-N-(4-(((((11S,11AS)-8-((5-(((11AS)-5,11A-DIHYDRO-7-METHOXY-2-METHYL-5-OXO-1H-PYRROLO(2,1-C)(1,4)BENZODIAZEPIN-8-YL)OXY)PENTYL)OXY)-11,11A-DIHYDRO-11-HYDROXY-7-METHOXY-2-METHYL-5-OXO-1H-PYRROLO(2,1-C)(1,4)BENZODIAZEPIN-10(5H)-YL)CARBONYL)OXY)METHYL)PHENYL)-L-ALANINAMIDE
ROVALPITUZUMAB TESIRINE [INN]
ROVALPITUZUMAB TESIRINE [USAN]
ROVALPITUZUMAB TESIRINE [WHO-DD]
SC0002
SC-002
SC16LD6.5
SC-16LD6.5
SC16LD6.5-ADC

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ROVALPITUZUMAB TESIRINE

Synonyms and Mappings

Resources